Novozymes A/S (CPH: NSIS.B)

Novozymes Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	TTM	2023	2022	2021	2020	2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	260.8	1,116	1,041	963	1,181	711
Cash & Short-Term Investments	260.8	1,116	1,041	963	1,181	711
Cash Growth	85.35%	7.20%	8.10%	-18.46%	66.10%	-1.66%
Accounts Receivable	700.6	3,772	3,605	2,988	2,555	3,107
Other Receivables	125.9	575	538	805	672	542
Receivables	826.5	4,347	4,143	3,793	3,227	3,649
Inventory	687.4	3,627	3,803	2,992	2,361	2,613
Prepaid Expenses	-	-	174	-	-	-
Other Current Assets	32.9	372	80	75	142	77
Total Current Assets	1,808	9,462	9,241	7,823	6,911	7,050
Property, Plant & Equipment	2,866	12,325	12,074	10,185	9,612	10,212
Long-Term Investments	25.7	205	223	29	33	59
Goodwill	5,571	1,975	2,007	2,020	1,098	965
Other Intangible Assets	4,692	2,557	2,691	3,004	1,456	961
Long-Term Deferred Tax Assets	254.8	1,762	1,623	1,637	1,339	1,161
Other Long-Term Assets	34.5	105	124	69	61	29
Total Assets	15,252	28,391	27,983	24,767	20,510	20,437
Accounts Payable	345.8	1,616	1,869	1,490	1,100	1,117
Accrued Expenses	-	820	693	685	583	748
Current Portion of Long-Term Debt	916.7	3,083	2,919	2,139	1,106	1,380
Current Portion of Leases	-	137	123	122	136	163
Current Income Taxes Payable	89.5	183	326	486	336	431
Current Unearned Revenue	18.7	119	138	163	89	104
Other Current Liabilities	259.9	1,304	895	588	811	792
Total Current Liabilities	1,631	7,262	6,963	5,673	4,161	4,735
Long-Term Debt	1,073	4,329	3,619	3,680	3,244	2,706
Long-Term Leases	-	232	288	360	386	453
Long-Term Unearned Revenue	111.9	152	129	98	-	-
Long-Term Deferred Tax Liabilities	1,410	1,965	1,653	1,337	1,204	879
Other Long-Term Liabilities	21.8	100	1,103	1,413	271	184
Total Liabilities	4,247	14,040	13,755	12,561	9,266	8,957
Common Stock	125.7	562	562	564	570	582
Retained Earnings	10,900	13,755	13,062	11,303	11,263	10,810
Comprensive Income & Other	-21.9	-339	213	-40	-600	76
Total Common Equity	11,004	13,978	13,837	11,827	11,233	11,468
Minority Interest	1.5	373	391	379	11	12
Shareholders' Equity	11,005	14,351	14,228	12,206	11,244	11,480
Total Liabilities & Equity	15,252	28,391	27,983	24,767	20,510	20,437
Total Debt	1,989	7,781	6,949	6,301	4,872	4,702
Net Cash (Debt)	-1,728	-6,665	-5,908	-5,338	-3,691	-3,991
Net Cash Per Share	-6.23	-23.99	-21.20	-19.05	-13.09	-13.93
Filing Date Shares Outstanding	277.9	464.62	276.6	277.11	279.33	281.34
Total Common Shares Outstanding	277.9	277.32	276.6	277.11	279.33	281.34
Working Capital	177	2,200	2,278	2,150	2,750	2,315
Book Value Per Share	39.60	50.40	50.03	42.68	40.21	40.76
Tangible Book Value	740.2	9,446	9,139	6,803	8,679	9,542
Tangible Book Value Per Share	2.66	34.06	33.04	24.55	31.07	33.92
Land	-	8,349	7,711	7,551	6,986	7,046
Machinery	-	16,104	15,243	14,654	13,381	13,556
Construction In Progress	-	1,766	2,896	876	682	662

Source: S&P Capital IQ. Standard template. Financial Sources.